Atea Pharmaceuticals reported cash from operations of -$37.08M and free cash flow of -$37.08M for the quarter ended Jun 2026, down 12.8% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -28.19M | 117.13M | -42.08M | -31.34M | -8.07M | -34.43M | -35.47M | -28.18M | -33.14M | -39.16M | -63.17M | -40.52M | -31.15M | -33.54M | -34.27M | -37.16M | -42.05M | -16.48M | -45.44M | -32.93M | ||||||||
| Share-based Compensation | 10.99M | 11.35M | 11.66M | 11.91M | 11.50M | 11.64M | 16.65M | 16.89M | 17.01M | 12.16M | 19.95M | 20.16M | 20.17M | 14.30M | 22.71M | 22.89M | 22.84M | 4.58M | 23.43M | 21.85M | ||||||||
| Cash from Operations | 22.60M | -75.42M | -59.01M | -19.19M | -21.24M | -21.55M | -29.85M | -16.12M | -17.59M | -21.83M | -39.87M | -42.20M | -23.04M | -30.40M | -30.56M | -32.87M | -40.38M | -28.22M | -46.39M | -37.08M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of Intangibles | 7.93M | 3.09M | 3.70M | 4.32M | 4.34M | 3.49M | 3.02M | 2.60M | 2.71M | 1.74M | 1.32M | 1.07M | 0.81M | 0.58M | 0.54M | |||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.01M | 0.01M | 0.01M | 0.04M | 0.11M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Account Payables | 11.49M | -17.66M | -0.88M | 10.23M | -12.77M | 1.43M | -1.85M | 3.26M | -3.57M | 3.86M | 16.89M | -15.67M | 0.32M | -1.33M | 2.93M | 1.46M | -5.33M | 9.43M | -3.50M | 0.61M | ||||||||
| Change in Accured Expenses | 9.69M | 10.60M | -28.01M | -13.57M | 2.48M | 1.49M | -4.16M | 0.65M | 6.41M | 9.76M | -7.82M | 1.11M | -1.60M | -5.12M | 0.35M | -2.95M | 5.52M | 9.73M | -2.71M | -5.64M | ||||||||
| Other Working Capital Changes | -1.36M | 4.74M | -0.28M | -2.72M | 7.47M | 1.77M | -2.31M | 0.86M | -4.57M | 4.16M | -5.08M | -3.12M | -0.06M | 2.34M | 0.64M | -2.38M | 0.94M | 2.33M | -1.97M | 1.86M | ||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital Expenditures | 0.70M | 1.22M | 0.02M | |||||||||||||||||||||||||
| Change in Acquisitions & Divestments | 91.89M | 181.11M | 199.78M | 146.78M | 75.00M | 224.00M | 131.95M | 106.23M | 55.10M | 208.25M | 116.02M | 56.08M | 90.38M | 104.28M | 68.12M | |||||||||||||
| Cash from Investing Activities | -0.04M | -1.88M | -486.98M | 33.49M | 24.48M | 46.56M | -58.51M | 27.77M | 56.80M | 124.69M | -122.01M | -3.37M | 85.61M | 15.29M | 41.30M | 46.59M | 29.74M | 34.31M | ||||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activities | 0.80M | 0.14M | 0.22M | 0.14M | 0.17M | 0.09M | 0.15M | 0.12M | 0.14M | 0.06M | 0.87M | |||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.21M | 0.30M | 2.90M | 0.48M | 0.36M | 0.61M | 0.28M | 0.39M | 0.06M | 0.39M | 0.69M | 0.62M | ||||||||||||||||
| Net Equity Issued and Repurchased | ||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||
| Cash from Financing Activities | 0.80M | 0.14M | 0.22M | 0.15M | 0.17M | 0.09M | 0.15M | 0.12M | -0.35M | -14.09M | -11.30M | 0.26M | ||||||||||||||||
| Change in Cash | 23.40M | -75.28M | -58.83M | -21.07M | -508.07M | 11.94M | -5.21M | 30.45M | -76.01M | 5.94M | 17.09M | 82.48M | -144.93M | -33.77M | 54.70M | -31.67M | -10.38M | 18.37M | -16.40M | -2.77M | ||||||||
| Free Cash Flow | 22.60M | -75.42M | -59.71M | -20.41M | -21.26M | -21.55M | -29.85M | -16.12M | -17.59M | -21.83M | -39.87M | -42.20M | -23.04M | -30.40M | -30.56M | -32.87M | -40.38M | -28.22M | -46.39M | -37.08M | ||||||||
| Net Cash Flow | 23.40M | -75.28M | -58.83M | -21.07M | -508.07M | 11.94M | -5.21M | 30.45M | -76.01M | 5.94M | 17.09M | 82.48M | -144.93M | -33.77M | 54.70M | -31.67M | -10.38M | 18.37M | -16.40M | -2.77M |